A bone marrow or blood stem cell transplant can be an important treatment option for certain leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes and other blood or immune-system disorders. Because transplantation is highly specialized, choosing a center involves much more than finding a well-known hospital. Patients may need expertise in donor matching, transplant conditioning, infection prevention, graft-versus-host disease management, cellular therapies and long-term survivorship care.
The United States has numerous major academic cancer centers with established hematopoietic stem cell transplantation and cellular therapy programs. The institutions discussed below are not presented as a numerical ranking. They are prominent centers worth researching based on their established transplant programs, cancer expertise and publicly documented services.
This guide explains what these centers offer, how autologous and allogeneic transplantation differ, what patients should investigate before choosing a program, and how hospital charges and insurance coverage can affect the financial side of treatment. Because programs, physicians, insurance networks and treatment availability change, patients should verify current information directly with the transplant center and their health plan.
What Is a Bone Marrow or Stem Cell Transplant?
A bone marrow transplant is more broadly known as a hematopoietic stem cell transplant (HSCT). According to the National Cancer Institute, stem cell transplants restore blood-forming stem cells in patients whose cells have been destroyed by high-dose chemotherapy, radiation therapy or disease.
Although the phrase “bone marrow transplant” remains widely used, stem cells can come from bone marrow, peripheral blood or umbilical cord blood. The source and type of transplant depend on the disease, treatment strategy, donor availability and individual medical circumstances.
Autologous Stem Cell Transplant
In an autologous transplant, a patient’s own blood-forming stem cells are collected and stored before intensive treatment. The cells are later returned to the patient’s bloodstream. This approach is commonly considered for selected patients with diseases such as multiple myeloma and certain lymphomas.
Because the cells come from the patient, there is no donor-versus-recipient immune reaction. However, the treatment still carries significant risks related to intensive chemotherapy, infection, low blood counts and other complications.
Allogeneic Stem Cell Transplant
An allogeneic transplant uses blood-forming stem cells from another person. The donor may be a matched relative, an unrelated volunteer donor or, in appropriate cases, a partially matched donor. Umbilical cord blood may also be considered in some circumstances.
Allogeneic transplantation introduces additional issues such as donor compatibility and graft-versus-host disease (GVHD), in which donor immune cells attack the recipient’s tissues. This makes experienced multidisciplinary care particularly important.
Why Transplant-Center Experience Matters
Stem cell transplantation is not a single procedure followed by a short recovery. It is a coordinated treatment process that may include disease evaluation, donor identification, stem cell collection, conditioning therapy, transplantation, infection prevention, blood-product support, management of immune complications and months or years of follow-up.
Depending on the patient’s situation, the care team may involve hematologist-oncologists, transplant physicians, infectious-disease specialists, pharmacists, nurses, dietitians, social workers, financial counselors and other specialists.
Prominent Bone Marrow Transplant Hospitals and Cancer Centers in the USA
The following institutions have established hematopoietic stem cell transplantation, blood cancer and/or cellular therapy programs. This is a research-oriented selection rather than a numbered ranking. The medically appropriate center for one patient may be very different from the right center for another.
| Medical Center | Location | Relevant Focus | Official Website |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | New York, NY | Blood cancers, stem cell transplantation, cellular therapy | MSK |
| MD Anderson Cancer Center | Houston, TX | Stem cell transplantation, leukemia, lymphoma, myeloma, cellular therapy | MD Anderson |
| Dana-Farber Cancer Institute | Boston, MA | Blood cancers, stem cell transplantation and cellular therapies | Dana-Farber |
| Fred Hutchinson Cancer Center | Seattle, WA | Blood and marrow transplantation, cellular immunotherapy | Fred Hutch |
| Mayo Clinic | Multiple U.S. locations | Blood disorders, stem cell transplantation, cellular therapy | Mayo Clinic |
| City of Hope | Duarte/Los Angeles area, CA | Hematologic malignancies, stem cell transplantation, cellular therapy | City of Hope |
| Stanford Medicine | Stanford, CA | Blood cancers, blood and marrow transplantation, cellular therapy | Stanford Health Care |
| Johns Hopkins | Baltimore, MD | Bone marrow transplantation, hematologic malignancies | Johns Hopkins Medicine |
Memorial Sloan Kettering Cancer Center
Location: New York, New York
Official website: Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSK) is a major cancer-focused academic institution. Its hematologic oncology services include care for leukemia, lymphoma, multiple myeloma and other blood disorders, alongside bone marrow transplantation and cellular therapy.
Why Patients May Research MSK
MSK may be particularly relevant to patients with complex hematologic malignancies who need evaluation at a center where transplant specialists work alongside disease-specific oncology teams. This multidisciplinary model can matter because transplantation is usually one component of a broader cancer treatment plan rather than an isolated procedure.
Patients should ask whether their specific diagnosis is commonly treated by the transplant program, whether transplantation is recommended at their stage of disease, what donor options could be considered and whether an appropriate clinical trial is available.
Cost and Insurance Considerations
Being evaluated by MSK does not automatically mean every component of care is covered by a particular insurance plan. Patients should verify the network status of the hospital, treating physicians, laboratories and other involved providers and determine whether prior authorization is required.
MD Anderson Cancer Center
Location: Houston, Texas
Official website: The University of Texas MD Anderson Cancer Center
MD Anderson is a major academic cancer center with extensive programs for hematologic malignancies and stem cell transplantation. Patients with leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes and related diseases may encounter teams spanning hematology, transplantation and cellular therapies.
Specialized Cancer Care
A large cancer center can be valuable when a patient’s condition requires coordination among several subspecialists. Depending on the disease, a treatment plan may include chemotherapy, targeted therapy, immunotherapy, transplantation or another cellular therapy.
Patients considering MD Anderson should ask how the center approaches their exact diagnosis, whether transplantation is recommended now or after another therapy, and what pre-transplant testing will be necessary.
Dana-Farber Cancer Institute
Location: Boston, Massachusetts
Official website: Dana-Farber Cancer Institute
Dana-Farber provides specialized care for hematologic malignancies and offers stem cell transplantation and cellular therapies through its clinical programs and academic medical collaborations.
Patients with complicated blood cancers may find it useful to seek evaluation at a center where disease-specific hematologists, transplant physicians and cellular therapy specialists can review the case together.
Questions Worth Asking
- Is transplantation recommended for my disease and current treatment stage?
- Would an autologous or allogeneic transplant be considered?
- How will a donor be selected if I need an allogeneic transplant?
- What complications are most relevant in my situation?
- How much time must I remain near the transplant center?
- What caregiver support will I need after discharge?
Fred Hutchinson Cancer Center
Location: Seattle, Washington
Official website: Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center has a longstanding role in blood and marrow transplantation research and clinical care. Its programs cover hematologic malignancies as well as transplantation and cellular immunotherapy.
The center may be relevant for patients seeking evaluation for complex blood cancers, transplantation or investigational treatment through an appropriate clinical trial. Research availability should never be interpreted to mean a particular experimental treatment is suitable for every patient; eligibility depends on the study and individual medical circumstances.
Mayo Clinic
Locations: Mayo Clinic operates major campuses in Minnesota, Arizona and Florida.
Official website: Mayo Clinic
Mayo Clinic treats a broad range of hematologic diseases and offers blood and marrow transplantation and cellular therapy services within its cancer programs. The institution’s multispecialty structure can be useful for patients whose cancer treatment is complicated by other medical conditions requiring specialist input.
What to Verify Before Traveling
Services are not necessarily identical at every Mayo Clinic location. Patients should confirm that the campus they are considering provides the exact transplant or cellular therapy needed and whether evaluation, transplantation and follow-up would all occur at the same location.
City of Hope
Location: California, with its principal academic cancer center in Duarte.
Official website: City of Hope
City of Hope is a cancer-focused institution with programs for leukemia, lymphoma, multiple myeloma and other hematologic conditions, as well as hematopoietic stem cell transplantation and cellular therapy.
Patients considering the institution can ask for a diagnosis-specific consultation rather than comparing centers solely on general reputation. This helps establish which therapies are actually relevant to the individual’s disease, prior treatments and current health.
Stanford Health Care
Location: Stanford, California
Official website: Stanford Health Care
Stanford provides specialized hematology and cancer care, including blood and marrow transplantation and cellular therapies. As an academic medical center, it also participates in clinical research relevant to blood cancers and transplant medicine.
Patients researching Stanford should compare the center’s experience with their particular disease, available transplant approach, required follow-up schedule and insurance arrangements rather than relying on the institution’s overall reputation alone.
Johns Hopkins
Location: Baltimore, Maryland
Official website: Johns Hopkins Medicine
Johns Hopkins provides bone marrow transplantation and hematologic cancer care through its cancer and transplant programs. Its work in transplantation includes approaches designed for patients with different donor circumstances.
For someone considering an allogeneic transplant, useful questions include which donor sources could be appropriate, how donor matching will be performed, what conditioning regimen might be considered and how the program manages graft-versus-host disease and infections.
How to Compare Bone Marrow Transplant Centers
A familiar hospital name is not enough to determine whether a program fits an individual case. A more useful comparison looks at disease-specific expertise, transplant approach, donor options, complications management, follow-up requirements and financial feasibility.
| Factor | What to Investigate |
|---|---|
| Disease expertise | Experience treating your exact leukemia, lymphoma, myeloma or other condition |
| Transplant type | Autologous, allogeneic and other donor-source options relevant to your case |
| Donor strategy | How the program searches for and evaluates potential donors |
| Cellular therapy | Whether therapies such as CAR T-cell treatment are relevant and available |
| Complication management | Expertise in infections, GVHD and other transplant-related complications |
| Clinical trials | Studies for which you might actually meet eligibility criteria |
| Location | Travel, housing and required time near the hospital |
| Insurance | Hospital, physician and treatment network status and authorization |
| Long-term care | Survivorship monitoring and coordination with local physicians |
Ask About Your Specific Disease, Not Just Transplant Volume
Two patients needing stem cell transplantation may have very different medical situations. One may have multiple myeloma and be evaluated for an autologous transplant. Another may have acute leukemia requiring an allogeneic transplant and donor search.
Ask how the transplant team manages patients with your specific diagnosis, age group, previous treatments and medical conditions. Published program-level information cannot replace an individualized consultation.
Ask What Happens If Complications Develop
Complications can occur during and after transplantation. These may include infections, organ toxicities and, after allogeneic transplantation, graft-versus-host disease. Ask how urgent problems are managed outside normal clinic hours and whether specialized transplant physicians are continuously available.
Consider Long-Term Follow-Up
Recovery does not end when the patient leaves the hospital. Immune recovery can take considerable time, and patients may need repeated blood tests, medications, vaccinations, monitoring for recurrence and assessment for late effects of treatment.
Someone who lives hundreds or thousands of miles from the transplant center should ask exactly how long they must remain nearby and how the center coordinates later care with a local oncologist.
Bone Marrow Transplant Costs in the United States
There is no single reliable price that represents what every U.S. patient will pay for a bone marrow transplant. Costs can vary dramatically based on the type of transplant, disease, donor requirements, conditioning therapy, complications, length of hospitalization, medications and insurance contract.
For that reason, a generic internet price should not be treated as a quote. An allogeneic transplant involving donor identification and complex post-transplant care can have a very different financial profile from an autologous transplant.
| Treatment / Service | Approximate Cost Considerations | Main Factors Affecting Price |
|---|---|---|
| Initial transplant evaluation | Varies by center and required testing | Consultations, imaging, laboratory tests, insurance contract |
| Stem cell collection | Patient-specific | Cell source, collection method, medications and processing |
| Donor-related services | Applicable primarily to allogeneic transplantation | Donor search, compatibility testing and collection arrangements |
| Conditioning treatment | Varies considerably | Drug regimen, radiation when used, disease and patient factors |
| Transplant hospitalization | No universal patient price | Length of stay, complications, medications and supportive care |
| Post-transplant follow-up | Continues beyond initial transplant episode | Laboratory monitoring, clinic visits, medications and complications |
| Travel and lodging | Usually separate from medical charges | Distance, duration near center and caregiver requirements |
Hospital Price Transparency
The Centers for Medicare & Medicaid Services hospital price transparency program requires U.S. hospitals to make certain pricing information publicly available. This can improve access to negotiated and cash-price information, but transplant care involves many interconnected services, making a single posted number difficult to interpret.
A hospital’s standard charge or cash price is not necessarily what an insured patient owes. Insurers negotiate rates, and patient responsibility depends on plan benefits and cost sharing.
Why the Final Bill Can Differ From an Estimate
A transplant episode can generate charges from multiple providers and services. Hospital facility charges, professional fees, laboratory services, imaging, pathology, medications and other services may not always appear as one simple bill.
Unexpected complications can also change the amount of care required. A patient who needs additional hospitalization, intensive monitoring or treatment for infection may have substantially different charges from someone with a less complicated course.
Questions to Ask the Financial Counselor
- Can you provide an individualized estimate for the proposed transplant?
- What services are included in that estimate?
- Are physician professional fees included?
- Are donor-search and donor-collection expenses included?
- Which services could be billed separately?
- What financial assistance programs may be available?
- Who should I contact if the treatment plan changes?
How Health Insurance Can Affect Transplant Care
Insurance is one of the most important practical considerations in choosing a U.S. transplant center. A hospital being “covered” does not necessarily mean every physician, laboratory, drug or service involved in treatment will have identical network status or cost-sharing rules.
| Insurance Term | What It Generally Means |
|---|---|
| In-network | A provider has contracted with the health plan under agreed payment terms. |
| Out-of-network | A provider does not participate in the plan’s contracted network, which may lead to different or higher patient costs depending on the plan and applicable protections. |
| Deductible | The amount a patient generally pays for covered services before certain plan payments begin. |
| Copayment | A fixed amount charged for certain covered services under the plan. |
| Coinsurance | The patient’s percentage share of the allowed cost for a covered service. |
| Out-of-pocket maximum | A plan-defined annual limit on certain in-network cost sharing for covered benefits; premiums and some other costs generally do not count toward it. |
| Prior authorization | Approval that a plan may require before a service is provided for it to qualify for coverage under plan rules. |
For general explanations of plan types and coverage concepts, patients can review HealthCare.gov. Medicare beneficiaries can obtain program information through Medicare.gov.
Verify More Than the Hospital Name
Before treatment, contact both the transplant center and the insurer. Ask the insurer to confirm benefits using the exact hospital, physicians and proposed services whenever possible.
- Confirm the transplant hospital’s network status.
- Confirm the transplant physician and other major specialists separately.
- Ask whether transplantation requires prior authorization.
- Ask whether the plan uses designated transplant centers or centers of excellence.
- Confirm coverage rules for donor-related services when applicable.
- Request an estimate of your deductible, copayments and coinsurance.
- Ask how prescription and specialty-drug benefits apply.
PPO and HMO Considerations
PPO plans often provide more flexibility to obtain care outside a preferred network, but out-of-network treatment may involve substantially different cost sharing. HMO plans generally place stronger restrictions on obtaining non-emergency care outside the network and may require referrals or authorization.
Actual rules depend on the specific policy, so the plan documents and insurer’s written confirmation matter more than the plan label alone.
Medicare and Medicaid
Eligibility and coverage depend on the patient’s circumstances and the specific treatment. Medicare beneficiaries should confirm coverage directly with Medicare and the transplant provider. Medicaid rules and participating providers vary by state.
Do not assume that a nationally known cancer center participates in every Medicare arrangement, Medicaid program or commercial insurance network.
CAR T-Cell Therapy vs. Stem Cell Transplantation
Patients researching major transplant hospitals often encounter information about CAR T-cell therapy. These are different forms of cellular therapy and should not be treated as interchangeable.
In CAR T-cell therapy, a patient’s T cells are collected and genetically modified so they can recognize a particular target on cancer cells. The National Cancer Institute’s CAR T-cell therapy information explains how this approach is being used for certain blood cancers.
Some patients may be evaluated for transplantation, CAR T-cell therapy or other treatments at different points in their disease. The choice depends on diagnosis, previous therapies, treatment response, eligibility and other clinical factors.
Finding a Stem Cell Donor
Patients undergoing allogeneic transplantation need donor stem cells. Human leukocyte antigen (HLA) matching plays a central role in evaluating potential donors.
A fully matched sibling may be an option for some patients, but many people do not have an appropriate related donor. Transplant programs can evaluate unrelated donor and alternative donor approaches when clinically appropriate.
The National Marrow Donor Program (NMDP) provides resources related to blood stem cell donation, donor matching and transplantation.
Questions About Donor Selection
- Will relatives need HLA testing?
- When should an unrelated donor search begin?
- Could a partially matched donor be considered?
- Could cord blood be an option?
- How does donor choice affect the proposed treatment schedule?
Preparing for a Transplant Consultation
A well-prepared consultation can make it easier to compare recommendations from different centers. Before the appointment, ask what medical records the transplant team needs.
Commonly requested information may include pathology reports, bone marrow biopsy results, laboratory results, imaging reports, treatment records and medication lists. The center may request actual pathology slides or imaging files rather than reports alone.
Questions to Bring to the Appointment
- Why is transplantation being considered in my case?
- What alternatives should I understand?
- Which transplant type would you consider and why?
- What testing is required before treatment?
- How would a donor be identified?
- What are the major short-term risks in my situation?
- What late effects require long-term monitoring?
- How long might I need to remain near the hospital?
- What caregiver support will be required?
- Who coordinates care with my local oncologist?
Traveling for Bone Marrow Transplant Treatment
Patients do not always live near a major transplant program. Travel can therefore become part of the treatment decision.
Ask the center about the expected length of the initial evaluation, hospitalization and outpatient monitoring period. Some patients may need to remain within a specified distance of the transplant hospital after discharge because complications can require rapid medical attention.
Families should also consider lodging, transportation, meals, caregiver time away from work and the cost of repeated travel. These expenses can be significant even when medical treatment is well insured.
International Patients
Some major U.S. academic medical centers have international patient services, but availability, payment arrangements and documentation requirements differ among institutions.
International patients should contact the hospital before making travel arrangements. Ask what records must be translated, whether the hospital requires an advance financial review, how estimates are issued, what deposit requirements may apply and how follow-up will be coordinated after returning home.
A medical visa or other U.S. immigration requirement is separate from medical acceptance by a hospital. Patients should use official U.S. government resources for current immigration and visa information rather than relying on a hospital article or informal online advice.
Clinical Trials and Advanced Blood Cancer Treatment
Academic transplant centers frequently participate in clinical research. Trials may study conditioning regimens, approaches to preventing or treating graft-versus-host disease, cellular therapies, new medicines and strategies for reducing relapse.
The existence of a clinical trial does not mean participation is necessarily preferable to established treatment. Every study has specific eligibility criteria, potential benefits, risks and research objectives.
Patients interested in research can search the U.S. government’s ClinicalTrials.gov database and discuss relevant studies with their oncology team.
How to Make a More Informed Hospital Decision
The right transplant center should be evaluated in the context of the patient’s exact cancer, disease status, previous treatment, donor situation, overall health, insurance coverage and ability to complete follow-up.
Start with clinical fit. Ask whether the program routinely manages your particular diagnosis and what treatment approach its specialists recommend. If the case is complicated or the treatment choice is uncertain, obtaining a second opinion from another established transplant center can provide additional perspective.
Next, consider practical feasibility. A highly specialized center several states away may require prolonged temporary relocation. That may be reasonable for some families but extremely difficult for others.
Finally, investigate the financial side before treatment whenever circumstances allow. Confirm network status, prior authorization, pharmacy coverage and estimated patient responsibility. Keep written records of conversations with the insurer and hospital financial team.
A strong choice is therefore not simply the hospital with the most recognizable name. It is a program with appropriate clinical expertise that can deliver the required treatment while meeting the patient’s medical, logistical and financial circumstances.
Frequently Asked Questions
What are some leading bone marrow transplant hospitals in the USA?
Prominent U.S. centers with established stem cell transplantation and blood cancer programs include Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, Dana-Farber Cancer Institute, Fred Hutchinson Cancer Center, Mayo Clinic, City of Hope, Stanford Health Care and Johns Hopkins. This is not a numerical ranking. The appropriate center depends on the patient’s diagnosis, transplant type, donor options, health status, insurance and geographic circumstances.
Which cancers can be treated with a bone marrow transplant?
Hematopoietic stem cell transplantation may be considered for selected patients with diseases including leukemia, lymphoma and multiple myeloma, as well as certain other blood, bone marrow and immune-system disorders. The appropriateness and type of transplantation depend on the exact disease, stage or risk characteristics, treatment response, previous therapies, age, health and other clinical factors. A hematologist or transplant specialist should determine whether transplantation is a reasonable treatment option.
What is the difference between a bone marrow transplant and a stem cell transplant?
“Bone marrow transplant” is commonly used as a general term, but hematopoietic stem cells can be obtained from bone marrow, peripheral blood or umbilical cord blood. For this reason, healthcare professionals often use the broader term hematopoietic stem cell transplantation. The best cell source depends on the type of transplant, donor and individual clinical circumstances.
How much does a bone marrow transplant cost in the United States?
There is no single nationwide price that accurately represents every transplant. Charges and patient responsibility can vary based on autologous versus allogeneic transplantation, donor services, conditioning treatment, hospital stay, complications, medications, laboratory work and insurance. Patients should request a personalized estimate from the transplant center and confirm their benefits with the insurer. A hospital’s published charge should not automatically be interpreted as the amount an insured patient will pay.
Does health insurance cover bone marrow transplantation?
Coverage depends on the health plan, medical circumstances, network rules and authorization requirements. Even when transplantation is a covered benefit, the patient may have deductibles, copayments or coinsurance. Plans may also have specific requirements concerning transplant centers and prior authorization. Patients should verify the hospital, transplant physician, proposed treatment and relevant donor services directly with their insurer before treatment whenever possible.
How do I know whether a transplant hospital is in-network?
Check both the insurer’s current provider information and the hospital’s insurance department, but do not stop at the hospital name. Ask the insurer to verify the facility, transplant physician and other major providers involved in care. Request confirmation of prior authorization requirements and an estimate of your cost sharing. Network contracts can change, so confirmation close to the planned treatment date is valuable.
How long do patients need to stay near a transplant center?
There is no universal timeline. The required period depends on the transplant type, treatment protocol, complications, immune recovery and center-specific follow-up practices. Some patients need close outpatient monitoring after leaving the hospital and may be required to remain near the transplant center. Ask the program for its specific expectations before arranging housing, caregiver leave or travel.
Can a patient get a bone marrow transplant without a matched sibling?
Potential donor options can extend beyond a fully matched sibling. Depending on the clinical situation, transplant teams may evaluate matched unrelated donors, partially matched related donors and other stem cell sources such as umbilical cord blood. Donor selection is medically complex and depends on factors including HLA compatibility, disease, transplant strategy and donor availability.
Is CAR T-cell therapy the same as a bone marrow transplant?
No. They are different cellular therapies. Stem cell transplantation restores blood-forming stem cells after conditioning treatment, while CAR T-cell therapy modifies a patient’s T cells so they can recognize specific targets on cancer cells. Depending on the disease and previous treatment, a specialist may consider one or both approaches at different stages of care.
Should I get a second opinion before a stem cell transplant?
A second opinion can be useful when treatment choices are complex, particularly if there are questions about transplant timing, donor strategy, alternative therapies or clinical trials. Another specialist may confirm the original recommendation or identify additional options. Patients should not delay medically urgent treatment solely to pursue multiple opinions; the timing and practicality of another consultation should be discussed with the treating team.
Choosing the Right Bone Marrow Transplant Center
Choosing among major U.S. bone marrow transplant hospitals requires more than comparing institutional reputation. Start by identifying centers with expertise in your exact disease and the type of transplant or cellular therapy being considered. Ask how the team approaches donor selection, complications, infection management, long-term follow-up and coordination with your local oncologist.
Then examine the practical details. Determine how long you may need to remain near the center, whether a caregiver is required, and what travel or temporary housing may involve. Confirm hospital and physician network status, prior authorization and the expected patient financial responsibility directly with your insurer and transplant center.
Most importantly, treatment decisions should reflect individual medical needs. A nationally prominent cancer center may be an excellent place to seek an opinion, but no institution is automatically the right choice for every person. Comparing clinical expertise, physician experience, treatment options, location, insurance coverage, estimated costs and follow-up requirements provides a much stronger basis for making an informed decision.
Medical Disclaimer: This article is for general informational purposes and is not a substitute for professional medical advice, diagnosis or treatment. Transplant eligibility, hospital services, treatment approaches, prices and insurance coverage can change. Confirm current information directly with qualified healthcare professionals, the hospital and your insurer.
